Some Complexities of Multiple Inhibitor Interactions in Fibrinolytic Systems

Summary

Human or canine fibrin polymers which are structurally altered by the combined action of plasmin and EACA show an increased resistance to digestion by trypsin, but not to digestion by chymotrypsin. These observations support the concept that EACA inhibition of fibrinolysis is to a variable extent a function of structural changes in the substrate, and that the changes may be related to the susceptibility of lysyl- and arginyl-sites attacked by plasmin and trypsin, but not by chymotrypsin.

In plasma, the fibrin modification reactions mediated by plasmin + EACA are analogous to those in purified systems, with quantitative differences resulting from the presence of other inhibitors, and perhaps from earlier gelation of the developing polymers.

This complexity of the action of EACA must be taken into account in comparing its effects with those of other inhibitors, which also have variable and non-linear effects related to prevention of autodigestion of plasmin, antagonistic or potentiative combinations of inhibitors, and interference with substrate conversion.

• References

• 1 Donaldson V.H. Activation of Partially Purified Plasminogen in the Presence of E-Amino-caproic Acid. J. Lab. clin. Med. 1964; 63: 213
• 2 Alkjaersig N, Fletcher A.P, Sherry S. E-Aminocaproic Acid: An Inhibitor of Plasminogen Activation. J. biol. Chem. 1959; 234: 832
• 3 Maxwell R.E, Lewandowski V, Nickel V.S. Effects of Some Amino Acids on the Inhibition of Plasmin by Aptiplasmin. Biochim. biophys. Acta (Amst.) 1965; 99: 342
• 4 Egeblad K. Effects of ɛ-Aminocaproic Acid on Fibrin Clot Lysis. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 15: 173
• 5 Maxwell R.E, Lewandowski V, Nickel V.S. Enhancement of Fibrinolysis and Antagonism of Antiplasmin by Reversible Plasmin Inhibitors. Life Sci. 1965; 4: 45
• 6 Ablondi F.B, Hagan J.J, Philips M, De Renzo E.C. Inhibition of Plasmin Trypsin, and the Streptokinase-Activated Fibrinolytic System by E-Aminocaproic Acid. Arch. Biochem. 1959; 82: 153
• 7 Celander D.R, Naschke M.D, Guest M.M. The Effect of E-Aminocaproic Acid on Fibrino-lysin and on Activators of Profibrinolysin. Texas Rep. Biol. Med. 1961; 19: 50
• 8 Blix S. The Effectiveness of Activators in Clot Lysis, with Special Reference to Fibrinolytic Therapy. Acta med. scand. 172, Suppl. 1962; 386: 1
• 9 Ambrus, C.M., J.L. Ambrus, H.B. Lassman, I.B. Mink: Studies on the Mechanism of Action of Inhibitors of the Fibrinolysis System. Ann. N. Y. Acad. Sci.(In Press.).
• 10 Maxwell R.E, Allen D. Interactions of E-Aminocaproic Acid with the Thrombin Clotting and Fibrinolytic Systems. Nature (Lond.) 1966; 209: 211
• 11 Maxwell R.E. Enhancement or Inhibition of Fibrinolysis by Reversible Plasmin Inhibitors. Fed. Proc. 1966; 25: 498
• 12 Maxwell R.E, Lewandowski V, Nickel V.S, Nawrocki J.W. Substrate Modification and the Mechanism of Potentiation of Plasmin Inhibition by ω-Amino Acids. Abstrs., Fifteenth Annual Symposium on Blood. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 18: 299
• 13 Maxwell R.E, Lewandowski V, Allen D. Fibrinolytic Assay Based on Turbidity of Polystyrene Particles Released from the Clot. Analyt. Biochem. 1966; 16: 53
• 14 Loomis E.C, Ryder A, George C. Fibrinolysin and Antifibrinolysin: Biochemical Concentration of Antifibriolysin. Arch. Biochem. 1949; 20: 444
• 15 Maxwell B.E, Nickel V.S, Lewandowshi V. Preparations of Plasminogen-Deficient Fibrinogen and Thrombin. Biochem. biophys. Res. Commun. 1962; 7: 50
• 16 Straughn III W, Wagner R.H. A Simple Method for Preparing Fibrinogen. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 16: 198
• 17 Maxwell R.E, Lewandowski V. Modified Fibrinolytic Technique for Analysis of the Plasmin System. Analyt. Biochem. 1962; 4: 407
• 18 Troll W, Sherry S, Wachman J. The Action of Plasmin on Synthetic Substrates. J. biol. Chem. 1954; 205: 85
• 19 Scheraga H.A. M. Laskowski, Jr.: The Fibrinogen-Fibrin Conversion. Advanc. Protein Chem. 1957; 12: 1
• 20 Endres G.F, Scheraga H.A. Equilibria in the Fibrinogen-Fibrin Conversion. VII. On the Mechanism of the Reversible Polymerization of Fibrin Monomer. Biochemistry (Wash.) 1966; 5: 1568
• 21 Fletcher A.P, Alkjaersig N, Fisher S, Sherry S. The Proteolysis of Fibrinogen by Plasmin: The Identification of Thrombin-Clottable Fibrinogen Derivatives Which Polymerize Abnormally. J. Lab. clin. Med. 1966; 68: 780
• 22 Hirsh J, Fletcher A.P, Sherry S. Effect of Fibrin and Fibrinogen Proteolysis Products on Clot Physical Properties. Amer. J. Physiol. 1965; 209: 415
• 23 Pechet L, Alexander B. The Effect of Certain Proteolytic Enzymes on the Thrombin-Fibrinogen Interaction. Biochemistry (Wash.). 1962; 1: 875
• 24 Triantaphyllopoulos D.C, Triantaphyllopoulos E. Evidence of Antithrombic Activity of the Anticoagulant Fraction of Incubated Fibrinogen. Brit. J. Haemat. 1966; 12: 145
• 25 Ferry J.D, Shulman S. The Conversion of Fibrinogen to Fibrin. I. Influence of Hydroxyl Compounds on Clotting Time and Clot Opacity. J. Amer. chem. Soc. 1949; 71: 3198
• 26 Von Korff B.W, Bronfenbrenner A. A Difference in Bovine and Human Fibrinopeptides with Respect to the Occurrence of Tyrosine-O-Sulfate. J. Amer. chem. Soc. 1958; 80: 5575
• 27 Blombäck B, Dolittle B.F. Amino Acid Sequence Studies on Fibrinoeptides from Several Species. Acta chem. scand. 1963; 17: 1819
• 28 Blombäck B, Blombäck M, Edman P, Kessel B. Human Fibrinopeptides. Isolation, Characterization and Structure. Biochim. biophys. Acta (Amst.) 1966; 115: 371
• 29 Mills D.A, Coyne R, Pollara B, Von Korff B.W. The Action of Plasmin on Fibrinogen and Fibrin I. Changes in the N-Terminal Residues. Biochim. biophys. Acta (Amst.) 1964; 86: 527
• 30 Bosenfeld L. Clot Opacity and the Thrombin-Plasma Reaction. Arch. Biochem. 1965; 111: 660
• 31 Ferry J.D, Morrison P.R. Preparation and Properties of Serum and Plasma Proteins. VIII. The Conversion of Human Fibrinogen to Fibrin Under Various Conditions. J. Amer. chem. Soc. 1947; 69: 388
• 32 Chandrasekhar N, Osbahr A, Kali K. The Mode of Action of the Laki-Lorand Factor in the Clotting of Fibrinogen. Biochem. biophys. Res. Commun. 1964; 15: 182
• 33 Lorand L, Doolittle R.F, Konishi K, Biggs S.K. A New Class of Blood Coagulation Inhibitors. Arch. Biochem. 1963; 102: 171
• 34 Abilgaard U. N-Terminal Analysis During Coagulation of Purified Human Fibrinogen. Fraction I, and Plasma. Scand. J. clin. Lab. Invest. 1965; 17: 529
• 35 Bimon A, Shamash Y, Shapiro B. The Plasmin Inhibitor of Human Plasma. IV. Its Action on Plasmin, Trypsin. Chymotrypsin, and Thrombin. J. biol. Chem. 1966; 241: 5102
• 36 Webb J.L. Enzyme Metabolic Inhibitors Vol. Academic Press I. N.Y. 1963
• 37 Bose I.A. Mechanisms of Enzyme Action. Ann. Rev. Biochem. 1966; 35: 23
• 38 Green N.M. Competition Among Trypsin Inhibitors. J. biol. Chem. 1953; 205: 535
• 39 Muramatu M, Onishi T, Makino S, Fujii S, Yamamura Y. Inhibition of Fibrinolytic Activity of Plasmin by Various Synthetic Inhibitors. J. Biochem. (Tokyo) 1965; 57: 450
• 40 Sjoerdsma A, Nilsson I.M. Aliphatic Amino Compounds as Inhibitors of Plasminogen Activation. Proc. Soc. exp. Biol. (N. Y.) 1960; 103: 533